Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01731392
Other study ID # 10.50.NRC
Secondary ID
Status Completed
Phase N/A
First received November 16, 2012
Last updated December 11, 2013
Start date November 2012
Est. completion date June 2013

Study information

Verified date December 2013
Source Nestlé
Contact n/a
Is FDA regulated No
Health authority Indonesia: Ethics Committee
Study type Interventional

Clinical Trial Summary

To investigate the effect of milk-based formulas on infections and immune functions in healthy children.


Description:

Particular attention was paid to the role played by nutrition in supporting the gut ecosystem, balancing microbiota and promoting health status. In that respect, the beneficial effects of probiotics were demonstrated for different infectious diseases, GII and URI.

The beneficial effect of probiotics for treatment of symptomatic diarrhea was clearly documented.


Recruitment information / eligibility

Status Completed
Enrollment 604
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 1 Year to 3 Years
Eligibility Inclusion Criteria:

- Parents written and signed informed consent for participation in the study.

- Healthy children aged 1 to 3 years that are no more breastfed.

- Go to a selected nursery and / or pediatrician.

- Parents must have a phone at home or a cellular phone to call the paediatrician.

- No consumption of commercial products containing probiotics or prebiotics during the 3 weeks before and during the study period.

- Parents are able to give their children, twice daily, 2 milk servings on a 5 months period.

- Children not being intensive consumers of regular yoghurts

Exclusion Criteria:

- Rotavirus and flu vaccines administration within the last 3 months prior to V1 (baseline visit).

- Used antibiotics within the last 30 days prior to V1 (baseline visit).

- Congenital or chronic disease.

- Any kind of immunodeficiency or allergy, milk protein allergy or lactose intolerance.

- Significant illness within the two weeks prior to start of the study or any active systemic infection or medical condition that may require treatment or therapeutic intervention during the study.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care


Intervention

Dietary Supplement:
Milk with Bifidobacteria
A total of 36g (4 spoons) of powder milk per serving are diluted in 220 ml of water. Two servings per day are consumed orally, corresponding to 72g per day.
Milk with non replicating lactobacilli
A total of 36g (4 spoons) of powder milk per serving are diluted in 220 ml of water. Two servings per day are consumed orally, corresponding to 72g per day.
placebo
A total of 36g (4 spoons) of powder milk per serving are diluted in 220 ml of water. Two servings per day are consumed orally, corresponding to 72g per day.

Locations

Country Name City State
Indonesia Dept. Nutrition, Faculty of Medicine University of Indonesia Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Nestlé

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Days with diarrhea during the 5 months of follow up No
Secondary Number of episodes of Upper Respiratory Infections 5 months No
Secondary Duration of episodes of Upper Respiratory Infections 5 months No
Secondary Severity of episodes of Upper Respiratory Infections 5 months No
See also
  Status Clinical Trial Phase
Completed NCT06283784 - Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients N/A
Recruiting NCT03851835 - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis Phase 3
Completed NCT04003181 - The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon N/A
Completed NCT03596827 - The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection N/A
Recruiting NCT05372068 - Cement flooRs AnD chiLd hEalth (CRADLE) N/A
Completed NCT03972618 - Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic N/A
Completed NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant N/A
Not yet recruiting NCT05052489 - Registry and Clinical Observation of Children With Diarrhoeal Disease
Completed NCT02541695 - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli N/A
Completed NCT02428647 - Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Completed NCT01739231 - Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults Phase 1/Phase 2
Completed NCT01968408 - Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children Phase 3
Not yet recruiting NCT01382199 - Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients Phase 3
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01371656 - Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Phase 3
Terminated NCT01472211 - Water-based Zinc Intervention Trial in Zinc Deficient Children Phase 0
Terminated NCT01048567 - Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly Phase 2
Completed NCT00914225 - Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya N/A
Completed NCT00760851 - Yogurt Study in Children 2-4 Years Old Attending Daycare Phase 3